Pacira BioSciences Inc (PCRX)
17.40
+0.36
(+2.14%)
USD |
NASDAQ |
Nov 21, 16:00
17.40
0.00 (0.00%)
After-Hours: 20:00
Pacira BioSciences Market Cap: 803.18M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 786.33M |
| November 19, 2024 | 772.48M |
| November 18, 2024 | 768.32M |
| November 15, 2024 | 766.48M |
| November 14, 2024 | 755.86M |
| November 13, 2024 | 759.55M |
| November 12, 2024 | 775.71M |
| November 11, 2024 | 808.03M |
| November 08, 2024 | 796.03M |
| November 07, 2024 | 817.27M |
| November 06, 2024 | 815.88M |
| November 05, 2024 | 797.87M |
| November 04, 2024 | 759.55M |
| November 01, 2024 | 765.09M |
| October 31, 2024 | 766.06M |
| October 30, 2024 | 778.52M |
| October 29, 2024 | 792.82M |
| October 28, 2024 | 790.52M |
| October 25, 2024 | 776.67M |
| October 24, 2024 | 785.44M |
| October 23, 2024 | 802.05M |
| October 22, 2024 | 813.59M |
| October 21, 2024 | 799.75M |
| October 18, 2024 | 807.13M |
| October 17, 2024 | 782.21M |
| Date | Value |
|---|---|
| October 16, 2024 | 767.44M |
| October 15, 2024 | 770.21M |
| October 14, 2024 | 753.14M |
| October 11, 2024 | 748.52M |
| October 10, 2024 | 715.76M |
| October 09, 2024 | 718.99M |
| October 08, 2024 | 722.68M |
| October 07, 2024 | 737.91M |
| October 04, 2024 | 762.14M |
| October 03, 2024 | 733.29M |
| October 02, 2024 | 716.68M |
| October 01, 2024 | 706.07M |
| September 30, 2024 | 694.53M |
| September 27, 2024 | 670.69M |
| September 26, 2024 | 661.00M |
| September 25, 2024 | 641.63M |
| September 24, 2024 | 657.77M |
| September 23, 2024 | 658.69M |
| September 20, 2024 | 670.22M |
| September 19, 2024 | 677.60M |
| September 18, 2024 | 675.76M |
| September 17, 2024 | 661.69M |
| September 16, 2024 | 622.25M |
| September 13, 2024 | 604.72M |
| September 12, 2024 | 587.20M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
539.68M
Minimum
Aug 09 2024
3.679B
Maximum
Apr 08 2022
2.085B
Average
2.091B
Median
Market Cap Benchmarks
| Cyclo Therapeutics Inc | 20.07M |
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
| iBio Inc | 22.42M |
| Theriva Biologics Inc | 3.561M |
Market Cap Related Metrics
| PS Ratio | 1.363 |
| Price to Book Value | 1.071 |
| Price to Free Cash Flow | 4.893 |
| Price | 17.40 |
| Earnings Yield | -11.56% |
| Operating PE Ratio | 9.283 |
| Normalized PE Ratio | 24.40 |